Manuscripts
Showing 1583 manuscripts.
Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices during Pregnancy and Postpartum
Citation
Yifan Yu, Kristina M. Brooks, Gustavo F. Doncel, Brookie M. Best, Mark A. Marzinke, Mark Mirochnick, Peter Anderson, Landon Myer, Connie Celum, Renee Heffron, Jenell Coleman, Dvora Joseph Davey, Craig W. Hendrix, Jeremiah D. Momper, Robert Bies, Rachel K. Scott. Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices during Pregnancy and Postpartum. Clinical Pharmacokinetics. 2025. 65: 133-148. PMID: 41222898Year
2025
Journal
Clinical Pharmacokinetics
Study
P1026S, IMPAACT 2026
Are Family Factors Differentially Associated with Externalizing Symptoms Among Youth with Perinatally Acquired HIV?
Citation
Deborah A G Drabick, Rafaella J Jakubovic, Abbey L Friedman, Valerie S Everett, George O Emory, Marianela Rosales Gerpe, Katherine M Deloreto, Aidan P Campagnolio, Mary Katherine Galante, Sharon Nachman, Kenneth D Gadow. Are Family Factors Differentially Associated with Externalizing Symptoms Among Youth with Perinatally Acquired HIV?. Child Psychiatry & Human Development. 2025. 56: 1559-1572. PMID: 38261149Year
2025
Journal
Child Psychiatry & Human Development
Study
P1055
Postpartum maternal monitoring for renal safety related to tenofovir exposure during breastfeeding in the PROMISE 1077BF randomized trial
Citation
Kristin Baltrusaitis, Camlin Tierney, Mary Glenn Fowler, Maxensia Owor, Teacler G. Nematadzira, Lynette Nyakudya, Haseena Cassim, Jeanne de Jager, Kathleen George, Barbara Heckman, Kevin Knowles, Renee Browning, George K. Siberry, Taha E. Taha, Lynda Stranix-Chibanda, PROMISE P1084s Study Team. Postpartum maternal monitoring for renal safety related to tenofovir exposure during breastfeeding in the PROMISE 1077BF randomized trial. Journal of AIDS. 2025. PMID: 41474755Year
2025
Journal
Journal of AIDS
Study
P1084s
Use of a Medication Management Algorithm in Depressed Youth Living with HIV: Secondary analysis of a multi-site randomized controlled trial
Citation
Graham J. Emslie, Beth D. Kennard, Kristin Baltrusaitis, Sophia M. Jones, Jessica M. Jones, Jaime Deville, Kathy Pitts, David E. Shapiro, Allison Eliscu, Larry K. Brown. Use of a Medication Management Algorithm in Depressed Youth Living with HIV: Secondary analysis of a multi-site randomized controlled trial. Journal of Child and Adolescent Psychopharmacology. 2025. PMID: 41182169Year
2025
Journal
Journal of Child and Adolescent Psychopharmacology
Study
IMPAACT 2002
HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study
Citation
Mark F Cotton, Patrick Jean-Philippe, Anne Coletti, Ellen G Chadwick, Jennifer Jao, Stephen A Spector, Mark Mirochnick, Edmund V Capparelli, Diane Costello, Joseph Szewczyk, Nicol Nicodimus, Lynda Stranix-Chibanda, Adeodata R Kekitiinwa, Violet Korutaro, Deborah Persaud, Christina Reding, Yvonne Bryson, Mary N Carrington, Bryan S Nelson, Sai Majji, Camlin Tierney, Dwight E Yin. HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study. Lancet HIV. 2024. 23: 2352-3018. PMID: 38061376Year
2024
Journal
Lancet HIV
Study
P1115
Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum
Citation
Risa M. Hoffman, Sean Brummel, Lauren Ziemba, Lameck Chinula, Jeffrey S A Stringer, Frances Nakayiwa, Avy Violari, Lee Fairlie, Victoria Ndyanabangi, Teacler G. Nematadzira, Sherika Hanley, Esau João, Linda Aurpibul, Mario Dias Correa Junior, Oranich Navanukroh, Neetal Nevrekar, Gerhard Theron, Cristina Barroso Hofer, Rebecca Zash, Roger Shapiro, Nahida Chakhtoura, Ben Johnston, Chelsea Krotje, Katie McCarthy, Patrick Jean-Philippe, Paul Sax, Judith S. Currier, Shahin Lockman, VESTED Study Team. Weight changes and adverse pregnancy outcomes with dolutegravir- and tenofovir alafenamide fumarate-containing antiretroviral treatment regimens during pregnancy and postpartum. Clinical Infectious Diseases. 2024. 78: 1617-1628. PMID: 38180851Year
2024
Journal
Clinical Infectious Diseases
Study
IMPAACT 2010
Bridging Dolutegravir Clinical Viral Response Across Doses and Formulations Using Model-Based Exposure-Response Analysis in Pediatrics
Citation
Hardik Chandasana, Rajendra Singh, Annie Buchanan, Cynthia Brothers, Andy Wiznia, Mattie Bartlett, Stephanie Popson, Ellen Townley, Rohan Hazra, Kathy George, Cindy Vavro, Theodore Ruel, Edward Acosta, IMPAACT P1093 Team. Bridging Dolutegravir Clinical Viral Response Across Doses and Formulations Using Model-Based Exposure-Response Analysis in Pediatrics. Journal of Acquired Immune Deficiency Syndromes. 2024. 8: F11-F18. PMID: 38768443Year
2024
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1093
Pharmacokinetics and Safety of Remdesivir in Pregnant and Non-Pregnant Women with COVID: Results from IMPAACT 2032
Citation
Kristina M. Brooks, Kristin Baltrusaitis, Diana F. Clarke, Sharon Nachman, Jennifer Jao, Murli Purswani, Allison Agwu, Christy Beneri, Jaime G. Deville, Kathleen Powis, Alice M. Stek, Ahizechukwu Eke, David E. Shapiro, Edmund Capparelli, Elizabeth Greene, Kathleen George, Dwight E. Yin, Patrick Jean-Philippe, Nahida Chakhtoura, Frederic Bone, Kira Bacon, Benjamin Johnston, Christina Reding, Kathryn Kersey, Rita Humeniuk, Brookie M. Best, Mark Mirochnick, Jeremiah D. Momper, IMPAACT 2032 Study Team. Pharmacokinetics and Safety of Remdesivir in Pregnant and Non-Pregnant Women with COVID: Results from IMPAACT 2032. Journal of Infectious Diseases. 2024. 230: 878-888. PMID: 38839047Year
2024
Journal
Journal of Infectious Diseases
Study
IMPAACT 2032
Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1
Citation
Hardik Chandasana, Sven C. van Dijkman, Rashmi Mehta, Mark Bush, Helena Rabie, Patricia Flynn, Tim R. Cressey, Edward P. Acosta, Kristina M. Brooks, IMPAACT 2019 Study Team. Population Pharmacokinetic Modeling of Abacavir/Dolutegravir/Lamivudine to Support a Fixed-Dose Combination in Children with HIV-1. Infectious Diseases and Therapy. 2024. PMID: 38961048Year
2024
Journal
Infectious Diseases and Therapy
Study
IMPAACT 2019
Impact of in-utero exposure to HIV and latent TB on infant humoral responses
Citation
Jyoti Mathad, Grace Montepiedra, Amita Gupta, Savita Pahwa, Kimberly J.S. Hjelmar, Lesley R. de Armas, Evan Goldberg, Suresh Pallikkuth. Impact of in-utero exposure to HIV and latent TB on infant humoral responses. Frontiers in Immunology. 2024. 15: 1423435. PMID: 38994354Year
2024
Journal
Frontiers in Immunology
Study
P1078